维普期刊资源整合服务平台（V6.5）

114篇 您的检索式：作者名="Farnier M"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Lipid-altering efficacy and safety profile of combination therapy with ezetimiber/statin versus statin monotherapy in patients with and without diabetes:an analysis of pooled data from 27 clincal trials显示文摘	Leiter LA Betteridge DJ Farnier M	2011	Diabetes Obes Metab2011，18，：	1
2	Effects of feanfibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipeprotein peak particle size in patients with mixed hyperlipidemia 显示文摘	Tribble DL Farnier M Macdonell G	2008	Metabolism2008，57，6：	1
3	Combination therapy with an HMG-CoA reductase inhibitor and a fibrie acid derivative 显示文摘	Farnier M	2003	Am J Cardiovase Drugs2003，3，：	1
4	PCSK9 inhibitors显示文摘	Farnier M		0，，：	1
5	Pravastatin and fenofibrate in combination (Pravafenix) for the treatment of hlgh-rlsk patients with mixed hyperlipidemia显示文摘	Farnier M	2012	Expert Rev Cardiovasc Ther2012，10，5：	1
6	The role of proprotein convertase subtilisin/kexin type 9 in hyperlipidemia: focus on therapeutic implications显示文摘	FARNIER M	2011	Am J Cardiovasc Drugs2011，11，3：	1
7	Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘	Robinson JG Farnier M Krempf M	2015	N Engl J Med2015，372，16：	1
8	Eficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia显示文摘	Farnier M Freeman MW Macdonell G	2005	Eur Heart J2005，26，9：	1
9	Lipid-altering efficacy of ezetimibe/simv-astatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy-The IN-CROSS study显示文摘	Farnier M Averna M Missault L	2009	International Journal of Clinical Practice2009，，04：	1
10	Effects of rosuvastatinand atorvastatin on the apolipoprotein B/apolipoprotein A-l ratioin patients with an acute coronary syndrome:The CENTAURUStrial design显示文摘	Lablanche JM Danchin N’Farnier M	2008	Arch Cardiovasc Dis2008，101，6：	1
11	Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixedhyperlipidemia not controlled by pravastatin monotherapy显示文摘	Farnier M Ducobu J Bryniarski L	2011	Curr Med Res Opin2011，27，11：	1
12	Effects of statins on biomarkers of bone metabolism: a randomized trial 显示文摘	Stein E A Farnier M Waldstreicher J	2001	Nutr Metab Cardivasc Dis2001，11，2：	1
13	Diabetes: statins, fibrates, or both 显示文摘	Farnier M Picard S	2001	Curr Atheroscler Rep2001，3，1：	1
14	PCSK9: from discovery to therapeutic applica- tions显示文摘	FARNIER M	2014	Archives Cardiovascular Diseases2014，107，1：	1
15	Effects of rosuvastatin and atorvastatin on the apollpoprotein βapolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS triai design 显示文摘	Lablanche JM Danchin N Farnier M et aI	2008	Arch Cardiovase DIS2008，101，6：	1
16	Lipid-altering efifcacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy-The IN-CROSS study显示文摘	Farnier M Averna M Missault L		0，，04：	1
17	Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high car- diovascular risk patients with poorly controlled hypercholesterol- emia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO Ⅰ and Ⅱ trials 显示文摘	Colhoun HM Robinson JG Farnier M	2014	B2vlC Cardiovasc Disord2014，14，：	1
18	High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction显示文摘	ZELLER M MASSON D FARNIER M	2007	J Am Coll Cardiol2007，50，20：	1
19	Relationship between alirocumab, PCSK9 and LDL-C levels :results from the odyssey mono phase 3 trial of alirocumab 75 mg every 2 weeks 显示文摘	Farnier M Kastelein J J P Roth E	2014	Atherosclerosis2014，235，2：	1
20	The role of proprotein convertase subtilisin/kex- in type 9 in hyperlipidemia: focus on therapeutic implications显示文摘	FARNIER M	2011	American Journal of Cardiovascular Drugs: Drugs Devices and Other Interventions2011，11，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示